FIELD: chemistry, pharmaceutics.
SUBSTANCE: invention relates to novel compounds of general formula 
, where R1 stands for halogen, (lower)alkyl, (lower)alkoxy, CF3 or cyano, R2 stands for aryl or heteroaryl, optionally containing one or several substitutes, selected from group which includes (lower)alkyl, halogen, R3 stands for hydrogen or CH2R5, where R5 stands for hydrogen or C1-C6alkyl, R4 stands for (lower)alkyl, X stands for N or CH, Y stands for -(CHR)1, 2 or 3, R stands for hydrogen or (lower)alkyl, and to its pharmaceutically acceptable salts. Invention also relates to method of obtaining compound of formula I, to medication, as well as to application of compounds on any of items 1-8.
EFFECT: obtaining novel biologically active compounds, intended for treatment and prevention of disorders mediated by mGluR5 receptor.
14 cl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETERO-ARYL SUBSTITUTED DERIVATIVES OF AMIDAZOLE AS ANTAGONISTS OF GLUTAMATE RECEPTORS | 2004 |
|
RU2327697C2 |
| NEW DERIVATIVES OF AMINOPYRIDINE AS ANTAGONISTS mGIuR5 | 2004 |
|
RU2330020C2 |
| IMIDAZOLE III DERIVATIVES | 2004 |
|
RU2360911C2 |
| IMIDAZOLE DERIVATIVES AS mGluR5 ANTAGONISTS | 2010 |
|
RU2527106C2 |
| PHENYLETHENYL- OR PHENYLETHYNYL-DERIVATIVES AS ANTAGONISTS OF GLUTAMATE RECEPTORS | 2001 |
|
RU2284323C9 |
| BENZOTHIAZOLE DERIVATIVES | 2001 |
|
RU2251419C2 |
| AMINOPYRAZINE COMPOUNDS WITH THE A2A ANTAGONIST PROPERTIES | 2015 |
|
RU2727805C2 |
| NEW ISOXAZOLIL ETHER DERIVATIVES AS PAM GABA A ALFA5 | 2019 |
|
RU2800160C2 |
| ARYL-ISOXAZOL-4-YL-IMIDAZO[1,2-a]PYRIDINE SUITABLE FOR TREATING ALZHEIMER'S DISEASE THROUGH GABA RECEPTORS | 2007 |
|
RU2426732C2 |
| DERIVATIVES OF PYRIDINE AND MEDICINAL AGENT BASED ON THEREOF POSSESSING SELECTIVE BLOCKING ACTIVITY WITH RESPECT TO SUBSPECIES OF NMDA-RECEPTORS | 2002 |
|
RU2303037C2 |
